2018
DOI: 10.1007/82_2018_111
|View full text |Cite
|
Sign up to set email alerts
|

Vaccines Against Escherichia coli

Abstract: Escherichia coli has a complex and versatile nature and continuously evolves from non-virulent isolates to highly pathogenic strains causing severe diseases and outbreaks. Broadly protective vaccines against pathogenic E. coli are not available and the rising in both, multi-drug resistant and hypervirulent isolates, raise concern for healthcare and require continuous efforts in epidemiologic surveillance and disease monitoring. The evolving knowledge on E. coli pathogenesis mechanisms and on the mediated immun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(40 citation statements)
references
References 139 publications
0
36
0
1
Order By: Relevance
“…Moreover, it continually encounters a large amount of exogenous agents derived from the diet and environment, as well as infectious microbes ( 2 ). Pathogenic agents such as bacteria, parasites and viruses are a major health and socio-economic burden in both humans and livestock ( 3 , 4 ). A major task of the gastrointestinal ecosystem is to maintain homeostasis in the presence of harmless dietary components and commensal microbiota, whilst eliciting an adequate protective inflammatory response in response to pathogens ( 5 ).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, it continually encounters a large amount of exogenous agents derived from the diet and environment, as well as infectious microbes ( 2 ). Pathogenic agents such as bacteria, parasites and viruses are a major health and socio-economic burden in both humans and livestock ( 3 , 4 ). A major task of the gastrointestinal ecosystem is to maintain homeostasis in the presence of harmless dietary components and commensal microbiota, whilst eliciting an adequate protective inflammatory response in response to pathogens ( 5 ).…”
Section: Introductionmentioning
confidence: 99%
“…In the case of ETEC infection, production of inflammatory cytokines in the mucosal barrier can be decoupled from the acquisition of protective immune mechanisms. Watery diarrhea and tissue damage results from the massive secretory actions of IEC following exposure to enterotoxin, and production of inflammatory mediators such as TNFα and IFNγ may contribute to accompanying fever and inappetence (Bosi et al, 2004;Nesta and Pizza, 2018). In humans, production of IFNγ appears to be associated with reduced clearance of ETEC infection, supporting the idea that the protective immune mechanisms are distinct from the proinflammatory cytokine response (Long et al, 2010).…”
Section: Polyphenolsmentioning
confidence: 98%
“…Recently, different vaccine strategies have been used for pathogenic E. coli infection as an alternative to antibiotic therapy ( Rojas-Lopez et al., 2018 ), including vaccines with attenuated toxins ( McKenzie et al., 2007 ; Bitzan et al., 2009 ), attenuated bacterial cell ( Calderon Toledo et al., 2011 ), individual components of virulence factors such as Shiga toxin ( Liu et al., 2009 ), EspA or Intimin ( Oliveira et al., 2012 ), small peptides ( Zhang et al., 2011 ), DNA ( García-Angulo et al., 2014 ) or polysaccharides ( Ahmed et al., 2006 ; van den Dobbelsteen, 2016 ), as well detailed in the literature. Commercial vaccines have aimed the use to protect livestock, such as poultry, swine and bovine herds, against respectively to APEC, like Poulvac® E. coli , ETEC and EHEC infections ( Sadeyen et al., 2015 ; Nesta and Pizza, 2018 ). Vaccines with a modern approach and technology still are a promising strategy to protect against emergent HyPECs infections in humans and livestock.…”
Section: Emerging Hybrids and Alternative Therapiesmentioning
confidence: 99%